Cell types in which OXT inhibits cell proliferation include neuroblastoma cells (IMR32, SH-N-SH, SH-SY5Y), epithelial cells (HUVEC, HAEC, HPAEC), adenocarcinoma of the endometrium, breast cancer cells (T47D, MDA-MB231), ovarian carcinoma (SKOV3), endometrial carcinoma (Colo684, A-MEC, HEC1A), prostate cancer cells (DU145), and osteosarcoma cells (MG-63, U2OS; for an overview of cell-types see Reversi et al., 2006b and references therein). Here, OXT is linked to prostate carcinoma.